Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1888 2
1892 3
1896 2
1901 2
1910 1
1918 1
1921 1
1933 1
1973 1
1974 1
1979 3
1980 4
1981 1
1983 5
1984 3
1985 2
1986 4
1987 7
1988 1
1989 5
1990 2
1991 6
1992 8
1993 10
1994 7
1995 11
1996 7
1997 8
1998 4
1999 11
2000 6
2001 11
2002 13
2003 9
2004 7
2005 7
2006 15
2007 10
2008 11
2009 13
2010 11
2011 14
2012 1
2013 3
2014 5
2015 8
2016 8
2017 11
2018 6
2019 9
2020 9
2021 10
2022 4
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

311 results

Results by year

Filters applied: . Clear all
Page 1
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
Kantarjian H, Thomas D, O'Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C, Beran M, Keating M, Freireich EJ. Kantarjian H, et al. Among authors: koller c. Cancer. 2004 Dec 15;101(12):2788-801. doi: 10.1002/cncr.20668. Cancer. 2004. PMID: 15481055 Free article. Clinical Trial.
Harms and Healing.
Koller C. Koller C. Milbank Q. 2022 Jun;100(2):323-326. doi: 10.1111/1468-0009.12573. Milbank Q. 2022. PMID: 35714592 Free PMC article. No abstract available.
Gemtuzumab ozogamicin with fludarabine, cytarabine, and granulocyte colony stimulating factor (FLAG-GO) as front-line regimen in patients with core binding factor acute myelogenous leukemia.
Borthakur G, Cortes JE, Estey EE, Jabbour E, Faderl S, O'Brien S, Garcia-Manero G, Kadia TM, Wang X, Patel K, Luthra R, Koller C, Brandt M, Ravandi F, Kantarjian H. Borthakur G, et al. Among authors: koller c. Am J Hematol. 2014 Oct;89(10):964-8. doi: 10.1002/ajh.23795. Epub 2014 Jul 21. Am J Hematol. 2014. PMID: 24990142 Free PMC article.
Blepharo-spasm.
Koller C. Koller C. Trans Am Ophthalmol Soc. 1888;5:161-6. Trans Am Ophthalmol Soc. 1888. PMID: 25259054 Free PMC article. No abstract available.
Heterogeneity of systematic reviews in oncology.
Holmes J, Herrmann D, Koller C, Khan S, Umberham B, Worley JA, Vassar M. Holmes J, et al. Among authors: koller c. Proc (Bayl Univ Med Cent). 2017 Apr;30(2):163-166. doi: 10.1080/08998280.2017.11929568. Proc (Bayl Univ Med Cent). 2017. PMID: 28405067 Free PMC article. Review.
Immune thrombocytopenic purpura.
Koller CA. Koller CA. Med Clin North Am. 1980 Jul;64(4):761-73. Med Clin North Am. 1980. PMID: 6995733 Review.
311 results